bezafibrate has been researched along with flunarizine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bizot-Espiard, JG; Coudert, G; Guillaumet, G; Lindenbaum, A; Pfeiffer, B; Renard, P; ThiƩry, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
2 other study(ies) available for bezafibrate and flunarizine
Article | Year |
---|---|
A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.
Topics: Animals; Antioxidants; Aorta, Thoracic; Calcium Channel Blockers; Copper; Dioxins; Dioxoles; Humans; Hypolipidemic Agents; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Piperazines; Rats; Structure-Activity Relationship | 2001 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |